Skip to content

Implementation of a short course of prophylactic antibiotic treatment for prevention of post operative infections in clean orthopedic surgeries after a randomized controlled trial"

Efficacy of a short course of prophylactic antibiotic treatment for prevention of post operative infections in open reduction and internal fixation of closed fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/091/000243
Enrollment
197
Registered
2011-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Closed Fracture with Open reduction and internal fixation

Interventions

Intervention1: Prophylatic Antibiotics- Cefurixime: Pre-Operation 1.5 Gms,Post operation 750 mg BD Control Intervention1: Prophylatic Antibiotics- Cefurixime and Amikacin: conventional long courses of

Sponsors

Indian Council Of Medical Research
Lead Sponsor
Indian Council Of Medical Research
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex, aged 18 years or more, who were scheduled for open reduction and internal fixation of closed fractures and was willing and able to give informed consent will be recruited to the trial. Only those patients suffering from closed fractures of limbs (upper/ lower) were included in the study.

Exclusion criteria

Exclusion criteria: The following patients will be excluded from the study: 1. Patients undergoing simple percutaneous kirschner wire fixation or external fixation. 2. Known hypersensitivity to cephalosporins, 3. Antimicrobial use or symptoms of infection in the week before surgery. 4. Pregnant females 5. Patients on immunosuppressive treatment 6. Patients suffering from compound fractures. 7. Patients suffering from multiple fractures. 8. Patients having underlying illnesses like diabetes, coronary artery disease, hypertension, chronic obstructive airway disease, any other chronic ailment.

Design outcomes

Primary

MeasureTime frame
No Infection at surgical siteTimepoint: 2 Months Followes

Secondary

MeasureTime frame
Cost effectivenessTimepoint: Two years

Countries

India

Contacts

Public ContactDr Purva Mathur
purvamathur@yahoo.co.in01126731268

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026